149 related articles for article (PubMed ID: 30873883)
1. In vitro model to compare the oxygen offloading behaviour of dodecafluoropentane emulsion (DDFPe).
Jayaraman MS; Graham K; Unger EC
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):783-789. PubMed ID: 30873883
[TBL] [Abstract][Full Text] [Related]
2. In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange.
Johnson JL; Dolezal MC; Kerschen A; Matsunaga TO; Unger EC
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(4):156-62. PubMed ID: 19548131
[TBL] [Abstract][Full Text] [Related]
3. Injectable oxygenation therapeutics: evaluating the oxygen delivery efficacy of artificial oxygen carriers and kosmotropes
Jayaraman MS; Graham K; Unger EC
Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):317-324. PubMed ID: 33739901
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the perfluorocarbon dodecafluoropentane as an adjunct to pre-hospital resuscitation.
Bonanno AM; Graham TL; Wilson LN; Madtson BM; Ross JD
PLoS One; 2018; 13(11):e0207197. PubMed ID: 30496190
[TBL] [Abstract][Full Text] [Related]
5. Dodecafluoropentane Emulsion (DDFPE) as a Resuscitation Fluid for Treatment of Hemorrhagic Shock and Traumatic Brain Injury: A Review.
Graham K; Moon-Massat PF; Unger EC
Shock; 2019 Oct; 52(1S Suppl 1):50-54. PubMed ID: 29176401
[TBL] [Abstract][Full Text] [Related]
6. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
Shah N; Mehra A
ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
[TBL] [Abstract][Full Text] [Related]
7. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
Riess JG
Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565
[TBL] [Abstract][Full Text] [Related]
8. Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme.
Lickliter JD; Ruben J; Kichenadasse G; Jennens R; Gzell C; Mason RP; Zhou H; Becker J; Unger E; Stea B
Cancer Res Commun; 2023 Aug; 3(8):1607-1614. PubMed ID: 37609003
[TBL] [Abstract][Full Text] [Related]
9. Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model.
Culp WC; Brown AT; Lowery JD; Arthur MC; Roberson PK; Skinner RD
Mol Neurobiol; 2015 Oct; 52(2):979-84. PubMed ID: 26055229
[TBL] [Abstract][Full Text] [Related]
10. Progress in dodecafluoropentane emulsion as a neuroprotective agent in a rabbit stroke model.
Woods SD; Skinner RD; Ricca AM; Brown AT; Lowery JD; Borrelli MJ; Lay JO; Culp WC
Mol Neurobiol; 2013 Oct; 48(2):363-7. PubMed ID: 23813100
[TBL] [Abstract][Full Text] [Related]
11. Oxygen solubility, rheology and hemodynamics of perfluorocarbon emulsion blood substitutes.
Millard RW
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):235-44. PubMed ID: 8087245
[TBL] [Abstract][Full Text] [Related]
12. Dodecafluoropentane emulsion delays and reduces MRI markers of infarction in a rat stroke model: a preliminary report.
Fitzgerald RT; Ou X; Nix JS; Arthur MC; Brown AT; Skinner RD; Borrelli MJ; Culp WC
Magn Reson Imaging; 2015 Feb; 33(2):236-9. PubMed ID: 25460332
[TBL] [Abstract][Full Text] [Related]
13. The use of semifluorinated alkanes in blood-substitutes.
Meinert H; Knoblich A
Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):583-95. PubMed ID: 8117848
[TBL] [Abstract][Full Text] [Related]
14. Oxidative assessment of phospholipid-stabilized perfluorocarbon-based blood substitutes.
Tarara TE; Malinoff SH; Pelura TJ
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1287-93. PubMed ID: 7849935
[TBL] [Abstract][Full Text] [Related]
15. Dodecafluoropentane (DDFPe) and decompression sickness-related mortality in rats.
Sheppard RL; Regis DP; Mahon RT
Aerosp Med Hum Perform; 2015 Jan; 86(1):21-6. PubMed ID: 25565529
[TBL] [Abstract][Full Text] [Related]
16. [Rheological behavior of blood substitutes with a perfluorocarbon base].
Draffehn J; Reichelt H
Pharmazie; 1991 Nov; 46(11):800-2. PubMed ID: 1725823
[TBL] [Abstract][Full Text] [Related]
17. A second-generation blood substitute (perflubron emulsion) increases the blood solubility of modern volatile anesthetics in vitro.
Cuignet OY; Baele PM; Van Obbergh LJ
Anesth Analg; 2002 Aug; 95(2):368-72, table of contents. PubMed ID: 12145053
[TBL] [Abstract][Full Text] [Related]
18. Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model.
Culp WC; Woods SD; Skinner RD; Brown AT; Lowery JD; Johnson JL; Unger EC; Hennings LJ; Borrelli MJ; Roberson PK
J Vasc Interv Radiol; 2012 Jan; 23(1):116-21. PubMed ID: 22079515
[TBL] [Abstract][Full Text] [Related]
19. Assessment of newly developed perfluorocarbon emulsion: oxygen carrying capacity as the blood substitute in vivo.
Sakanoue J; Tamura M; Fukushima S; Takeuchi Y; Sakuma I; Kitabatake A
Artif Cells Blood Substit Immobil Biotechnol; 2001 Sep; 29(5):389-97. PubMed ID: 11708662
[TBL] [Abstract][Full Text] [Related]
20. Clinical potential of intravenously administered perfluorocarbons.
Habler O; Kleen M; Messmer K
Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
